Paper908023
Temporal acquistion of enhanced fibrinolytic activity by syrian hamster embryo cells following treatment with benzo(a)pyrene.
Barrett JC and 6 others. Cancer Res, 1977. Cited by 73 papers, by iCite.
Cite this record
ConductScience Library. Temporal acquistion of enhanced fibrinolytic activity by syrian hamster embryo cells following treatment with benzo(a)pyrene. Papers, record 908023. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/908023
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Temporal acquistion of enhanced fibrinolytic activity by syrian hamster embryo cells following treatment with benzo(a)pyrene.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Benzopyrenes | Major topic |
| Cell Transformation, Neoplastic | Major topic |
| Fibrinolysis | Major topic |
| Cells, Cultured | |
| Clone Cells | |
| Culture Media | |
| Fibrin | |
| Sepharose | |
| Time Factors |
Source PubMed
Cited by19
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 73 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 21849266 | Functional significance of the ATP-binding cassette transporter B6 in hepatocellular carcinoma. | Mol Oncol | 2011 | https://conductscience.org/library/papers/21849266 | PubMed |
| 8248140 | Automatic enumeration and characterization of heterogeneous clonal progression in cell transformation. | Proc Natl Acad Sci U S A | 1993 | https://conductscience.org/library/papers/8248140 | PubMed |
| 7426322 | Increased ability of ethylnitrosourea-exposed brain cells to survive suspension in agar. | Br J Cancer | 1980 | https://conductscience.org/library/papers/7426322 | PubMed |
| 7193044 | Effect of 12-O-tetradecanoylphorbol-13-acetate on two charateristics of transformation acquired sequentially by ENU-exposed rat brain cells. | Br J Cancer | 1980 | https://conductscience.org/library/papers/7193044 | PubMed |
| 7192286 | Plasminogen activator induction and platelet aggregation by phorbol and some of its derivatives: correlation with skin irritancy and tumor-promoting activity. | J Cancer Res Clin Oncol | 1980 | https://conductscience.org/library/papers/7192286 | PubMed |
| 6865945 | Neoplastic conversion of preneoplastic Syrian hamster cells: rate estimation by fluctuation analysis. | Mol Cell Biol | 1983 | https://conductscience.org/library/papers/6865945 | PubMed |
| 6808514 | Monoclonal antibody that specifically inhibits a human Mr 52,000 plasminogen-activating enzyme. | Proc Natl Acad Sci U S A | 1982 | https://conductscience.org/library/papers/6808514 | PubMed |
| 6453346 | Activation of plasminogen to plasmin by a protease associated with the outer membrane of Escherichia coli. | Proc Natl Acad Sci U S A | 1981 | https://conductscience.org/library/papers/6453346 | PubMed |
| 6295922 | Chemical carcinogen-mouse mammary tumor virus interactions in cell transformation. | In Vitro | 1983 | https://conductscience.org/library/papers/6295922 | PubMed |
| 6246527 | Protease-activated "prodrugs" for cancer chemotherapy. | Proc Natl Acad Sci U S A | 1980 | https://conductscience.org/library/papers/6246527 | PubMed |
| 3008561 | In vitro inhibition of human sarcoma cells' invasive ability by bis(5-amidino-2-benzimidazolyl)methane--a novel esteroprotease inhibitor. | Am J Pathol | 1986 | https://conductscience.org/library/papers/3008561 | PubMed |
| 1493583 | An evaluation of three pesticides: piritione, supercypermethrin and metolachlor in transformation bioassays of BHK21 and hamster embryo cells. | Cell Biol Toxicol | 1992 | https://conductscience.org/library/papers/1493583 | PubMed |
| 492323 | Tumour promoters enhance anchorage-independent growth of adenovirus-transformed cells without altering the integration pattern of viral sequences. | Nature | 1979 | https://conductscience.org/library/papers/492323 | PubMed |
| 486316 | Correlation of in vitro transformation with in vivo tumorigenicity in 10T1/2 mouse cells exposed to UV light. | Br J Cancer | 1979 | https://conductscience.org/library/papers/486316 | PubMed |
| 284417 | Chemical carcinogens produce mutations to ouabain resistance in transformable C3H/10T1/2 Cl 8 mouse fibroblasts. | Proc Natl Acad Sci U S A | 1979 | https://conductscience.org/library/papers/284417 | PubMed |
| 278986 | Evidence for the progressive nature of neoplastic transformation in vitro. | Proc Natl Acad Sci U S A | 1978 | https://conductscience.org/library/papers/278986 | PubMed |
| 225525 | Neoplastic transformation of cultured Syrian hamster embryo cells by DNA of herpes simplex virus type 2. | J Virol | 1979 | https://conductscience.org/library/papers/225525 | PubMed |
| 156038 | Plasminogen activation transforms the morphology of quiescent 3T3 cell monolayers and initiates growth. | Br J Cancer | 1979 | https://conductscience.org/library/papers/156038 | PubMed |
| 150600 | Relationship between somatic mutation and neoplastic transformation. | Proc Natl Acad Sci U S A | 1978 | https://conductscience.org/library/papers/150600 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/908023
GET https://conductscience.org/api/papers/v1/908023/authors